UBS Group
MSLI

UBS Group’s Merus Labs International Inc. MSLI Stock Holding History

UBS Group’s Portfolio MSLI Stock Details MSLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,611
Closed -$16K – 8355
2017
Q2 		$16K Buy
12,611
+11,073
+720% +$11.5K ﹤0.01% 6482
2017
Q1 		$1K Sell
1,538
-396
-20% -$341 ﹤0.01% 7545
2016
Q4 		$2K Sell
1,934
-6,952
-78% -$6.39K ﹤0.01% 7568
2016
Q3 		$9K Buy
8,886
+6,506
+273% +$7.34K ﹤0.01% 6879
2016
Q2 		$3K Sell
2,380
-1,972
-45% -$2.76K ﹤0.01% 7381
2016
Q1 		$6K Sell
4,352
-2,681
-38% -$3.73K ﹤0.01% 6965
2015
Q4 		$12K Sell
7,033
-1,427
-17% -$1.94K ﹤0.01% 7197
2015
Q3 		$11K Sell
8,460
-186
-2% -$369 ﹤0.01% 7236
2015
Q2 		$20K Buy
8,646
+6,819
+373% +$16.5K ﹤0.01% 6888
2015
Q1 		$4K Sell
1,827
-2,728
-60% -$5.03K ﹤0.01% 8266
2014
Q4 		$8K Buy
+4,555
New +$6.63K ﹤0.01% 8653

UBS Group's MSLI Position: Q3 2017 in Review

UBS Group sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 12,611 shares — an estimated $16K sold.

UBS Group first reported a position in MSLI in Q4 2014 and held it in 11 quarters. The position peaked at $20K in Q2 2015. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.

  • UBS Group reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 12,611 Merus Labs International Inc. shares in Q3 2017, an estimated $16K.
  • UBS Group first reported a position in Merus Labs International Inc. in Q4 2014 and held it in 11 quarters.
  • UBS Group's Merus Labs International Inc. position peaked at $20K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.